Clinical Trial Update: A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing LY900014 to insulin lispro in children and adolescents with type 1 diabetes; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• LY900014
• insulin lispro (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2022-01-24